GlaxoSmithKline and Sirna Enter Major RNAi Collaboration
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 71 (Table of Contents)
Published: 6 May-2006
DOI: 10.3833/pdr.v2006.i71.515 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Global giant GlaxoSmithKline has entered into a multiyear collaboration with Sirna Therapeutics to develop novel RNAi-based therapeutics for respiratory diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018